New York: 20:20 || London: 01:20 || Mumbai: 04:50 || Singapore: 07:20

Recommendations » UK

IS Pharma (LON:ISPH.L) report: Interim results and placing

November 11, 2010, Thursday, 00:46 GMT | 19:46 EST | 05:16 IST | 07:46 SGT
Contributed by Daniel Stewart & Company


By Daniel Stewart & Co

 

- IS Pharma announced its Interim Results for the six months ended 30 September 2010.


- Revenue was up 10% to ?6.5m (H1 2009: ?5.9m)


- Profit after tax was up 192% to ?1.1m (H1 2009: ?0.4m)


- The company also announced that it raised ?12.5 million gross (?12.0 million net of expenses) through the placing of 15,625,000 new ordinary shares at 80 pence per share.